Sera Prognostics, Inc. (SERA): Capital Expenditures
$726.0K
Year ended 2025-12-31
$466.0K
Trailing 12 months to 2026-06-30
-2.8%
3-year compound annual growth
+37.3%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $726.0K | n/m | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $56.0K | -56.3% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | $128.0K | -83.8% | 2025-03-19, From 2023-01-01 |
| 2022-12-31 | $791.0K | -39.3% | 2024-03-20, From 2022-01-01 |
| 2021-12-31 | $1.30M | +775.2% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $149.0K | n/a | 2022-03-29, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $726.0K | n/m |
| Aclarion, Inc. (ACON) | 2025-12-31 | $21.5K | +320.9% |
| YD Bio Ltd (YDES) | 2025-12-31 | $1.44M | n/m |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $37.0K | -83.7% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $7.63M | -3.8% |
| CapForce Inc. (CFOR) | 2025-12-31 | $50.0K | n/a |
| Exagen Inc. (XGN) | 2025-12-31 | $641.0K | +24.5% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $4.50M | +181.0% |
| Biodesix Inc (BDSX) | 2025-12-31 | $259.0K | -92.0% |
Compare SERA, ACON, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗